Company / Assets per Share
Enliven Therapeutics, Inc. Assets per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.92
FY2024
5-year range
$4.32 / $26.66
FY2020-FY2024
Trend
-9.5%
vs FY2023
Sector context
#125 of 210
Health Care
What the data says
At $6.92, Enliven Therapeutics, Inc.'s assets per share ranks #125 of 210 in the Health Care sector. Declined from $26.66 to $6.92 over the past 2 years.
Based on SEC 10-K filings.
6.92 in FY2024 with a 5-year CAGR of -31.9%.
Declined from $26.66 to $6.92 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +17.0%
- 5-Year CAGR
- -31.9%
- 10-Year CAGR
- -
Sector benchmark
#125 of 210 in Health CareTop 60% of 210This company $6.92 Sector average $296.79
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2024, assets per share decreased 9.5% year-over-year.
- Ranks #125 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.84 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.92 | -9.5% |
| FY2023 | $7.65 | -71.3% |
| FY2022 | $26.66 | +516.7% |
| FY2021 | $4.32 | -33.7% |
| FY2020 | $6.52 | -86.2% |
| FY2019 | $47.40 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026